US Stock MarketDetailed Quotes

AMLX Amylyx Pharmaceuticals

Watchlist
  • 5.565
  • +0.025+0.45%
Trading Dec 2 13:26 ET
381.47MMarket Cap-1456P/E (TTM)

Amylyx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
106.63%11.92M
127.27%13.55M
88.00%-5.17M
118.53%8.61M
87.52%-5.07M
-140.47%-179.87M
-75.96%-49.7M
Net income from continuing operations
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
124.84%49.27M
111.08%4.73M
138.87%20.89M
140.83%22.07M
103.29%1.57M
-125.60%-198.38M
-50.66%-42.7M
Depreciation and amortization
-26.82%221K
-25.98%208K
54.41%315K
123.41%1.09M
65.38%301K
83.03%302K
167.62%281K
482.86%204K
836.54%487K
727.27%182K
Other non cash items
--36.2M
--805K
--22K
----
----
----
----
----
----
----
Change In working capital
68.89%-10.6M
59.95%-8.7M
101.43%164K
-3,901.28%-65.66M
113.65%1.56M
-770.70%-34.06M
-1,241.59%-21.71M
-511.02%-11.45M
-135.71%-1.64M
-926.64%-11.41M
-Change in receivables
-53.71%2.24M
200.22%16.56M
1,092.74%19.82M
-66.82%-24.72M
24.46%-11.04M
2,719.46%4.85M
-137,625.00%-16.53M
-199,500.00%-2M
-10,190.97%-14.82M
-10,053.47%-14.62M
-Change in inventory
--0
--0
30.44%-9.25M
-648.58%-73.13M
-187.65%-26.48M
-2,388.81%-14.01M
---19.33M
---13.3M
---9.77M
---9.21M
-Change in prepaid assets
161.15%3.84M
140.47%3.76M
27.00%-2.1M
7.74%-4.82M
218.66%2.78M
-634.75%-6.28M
86.86%1.56M
41.06%-2.88M
-16.38%-5.22M
13.96%-2.34M
-Change in payables and accrued expense
10.48%-16.6M
-329.20%-28.96M
-224.14%-8.43M
34.30%37.48M
146.96%36.59M
-507.45%-18.54M
1,524.29%12.64M
-12.52%6.79M
206.66%27.91M
744.27%14.82M
-Change in other current assets
10.81%492K
11.69%497K
55.28%677K
32.99%1.57M
-43.09%243K
6.22%444K
6.97%445K
631.71%436K
843.20%1.18M
--427K
-Change in other current liabilities
-10.60%-574K
-10.82%-553K
-10.59%-543K
-122.57%-2.04M
-10.60%-532K
-64.24%-519K
-326.50%-499K
-16,266.67%-491K
---917K
---481K
Cash from discontinued investing activities
Operating cash flow
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
106.63%11.92M
127.27%13.55M
88.00%-5.17M
118.53%8.61M
87.52%-5.07M
-140.47%-179.87M
-75.96%-49.7M
Investing cash flow
Cash flow from continuing investing activities
135.91%38.82M
-123.50%-28.96M
-98.54%819K
138.52%92.05M
109.17%20.93M
-228.61%-108.09M
2,661.59%123.22M
156.38%55.99M
-414.99%-238.99M
-8,208.74%-228.18M
Net PPE purchase and sale
105.32%19K
67.99%-89K
73.20%-67K
50.87%-1.24M
42.58%-356K
22.22%-357K
74.84%-278K
26.90%-250K
-615.58%-2.53M
-233.33%-620K
Net investment purchase and sale
169.62%75M
-123.38%-28.87M
-98.42%886K
139.45%93.29M
109.35%21.28M
-227.49%-107.73M
2,118.43%123.5M
156.83%56.24M
-413.46%-236.46M
-7,685.33%-227.56M
Cash from discontinued investing activities
Investing cash flow
135.91%38.82M
-123.50%-28.96M
-98.54%819K
138.52%92.05M
109.17%20.93M
-228.61%-108.09M
2,661.59%123.22M
156.38%55.99M
-414.99%-238.99M
-8,208.74%-228.18M
Financing cash flow
Cash flow from continuing financing activities
-91.00%80K
-98.05%27K
-87.40%131K
-99.18%3.54M
-99.90%230K
889K
267.15%1.38M
-99.48%1.04M
172.41%431.79M
21,899.25%232.16M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--0
----
Net common stock issuance
----
----
----
--0
----
----
----
----
--432.45M
--231.55M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
-50.10%491K
-97.79%47K
-59.14%1.45M
219.51%6.99M
-82.12%347K
--984K
756.45%2.12M
--3.54M
538.19%2.19M
1,238.62%1.94M
Net other financing activities
-332.63%-411K
97.30%-20K
47.38%-1.32M
-21.22%-3.45M
91.20%-117K
---95K
31.23%-740K
-465.38%-2.5M
-4.17%-2.85M
-14.97%-1.33M
Cash from discontinued financing activities
Financing cash flow
-91.00%80K
-98.05%27K
-87.40%131K
-99.18%3.54M
-99.90%230K
--889K
267.15%1.38M
-99.48%1.04M
172.41%431.79M
21,899.25%232.16M
Net cash flow
Beginning cash position
-69.53%75.72M
48.57%171.27M
170.25%170.92M
25.54%63.25M
25.38%135.98M
266.17%248.48M
4.02%115.28M
25.54%63.25M
285.58%50.38M
41.09%108.45M
Current changes in cash
97.62%-2.67M
-171.70%-95.51M
-99.11%461K
731.52%107.52M
175.92%34.71M
-374.32%-112.37M
411.05%133.22M
-14.13%51.96M
-65.34%12.93M
-72.54%-45.72M
Effect of exchange rate changes
276.12%236K
-116.67%-39K
-246.67%-110K
346.15%160K
-53.25%237K
63.69%-134K
86.67%-18K
210.29%75K
-600.00%-65K
5,533.33%507K
End cash Position
-46.11%73.28M
-69.53%75.72M
48.57%171.27M
170.25%170.92M
170.25%170.92M
25.38%135.98M
266.17%248.48M
4.02%115.28M
25.54%63.25M
25.54%63.25M
Free cash flow
-651.92%-41.55M
-900.25%-66.67M
89.55%-556K
105.85%10.68M
126.22%13.2M
87.31%-5.53M
117.51%8.33M
87.01%-5.32M
-142.70%-182.4M
-76.99%-50.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -704.22%-41.57M -873.38%-66.58M 90.36%-489K 106.63%11.92M 127.27%13.55M 88.00%-5.17M 118.53%8.61M 87.52%-5.07M -140.47%-179.87M -75.96%-49.7M
Net income from continuing operations -447.98%-72.7M -429.35%-72.7M -7,652.00%-118.79M 124.84%49.27M 111.08%4.73M 138.87%20.89M 140.83%22.07M 103.29%1.57M -125.60%-198.38M -50.66%-42.7M
Depreciation and amortization -26.82%221K -25.98%208K 54.41%315K 123.41%1.09M 65.38%301K 83.03%302K 167.62%281K 482.86%204K 836.54%487K 727.27%182K
Other non cash items --36.2M --805K --22K ---- ---- ---- ---- ---- ---- ----
Change In working capital 68.89%-10.6M 59.95%-8.7M 101.43%164K -3,901.28%-65.66M 113.65%1.56M -770.70%-34.06M -1,241.59%-21.71M -511.02%-11.45M -135.71%-1.64M -926.64%-11.41M
-Change in receivables -53.71%2.24M 200.22%16.56M 1,092.74%19.82M -66.82%-24.72M 24.46%-11.04M 2,719.46%4.85M -137,625.00%-16.53M -199,500.00%-2M -10,190.97%-14.82M -10,053.47%-14.62M
-Change in inventory --0 --0 30.44%-9.25M -648.58%-73.13M -187.65%-26.48M -2,388.81%-14.01M ---19.33M ---13.3M ---9.77M ---9.21M
-Change in prepaid assets 161.15%3.84M 140.47%3.76M 27.00%-2.1M 7.74%-4.82M 218.66%2.78M -634.75%-6.28M 86.86%1.56M 41.06%-2.88M -16.38%-5.22M 13.96%-2.34M
-Change in payables and accrued expense 10.48%-16.6M -329.20%-28.96M -224.14%-8.43M 34.30%37.48M 146.96%36.59M -507.45%-18.54M 1,524.29%12.64M -12.52%6.79M 206.66%27.91M 744.27%14.82M
-Change in other current assets 10.81%492K 11.69%497K 55.28%677K 32.99%1.57M -43.09%243K 6.22%444K 6.97%445K 631.71%436K 843.20%1.18M --427K
-Change in other current liabilities -10.60%-574K -10.82%-553K -10.59%-543K -122.57%-2.04M -10.60%-532K -64.24%-519K -326.50%-499K -16,266.67%-491K ---917K ---481K
Cash from discontinued investing activities
Operating cash flow -704.22%-41.57M -873.38%-66.58M 90.36%-489K 106.63%11.92M 127.27%13.55M 88.00%-5.17M 118.53%8.61M 87.52%-5.07M -140.47%-179.87M -75.96%-49.7M
Investing cash flow
Cash flow from continuing investing activities 135.91%38.82M -123.50%-28.96M -98.54%819K 138.52%92.05M 109.17%20.93M -228.61%-108.09M 2,661.59%123.22M 156.38%55.99M -414.99%-238.99M -8,208.74%-228.18M
Net PPE purchase and sale 105.32%19K 67.99%-89K 73.20%-67K 50.87%-1.24M 42.58%-356K 22.22%-357K 74.84%-278K 26.90%-250K -615.58%-2.53M -233.33%-620K
Net investment purchase and sale 169.62%75M -123.38%-28.87M -98.42%886K 139.45%93.29M 109.35%21.28M -227.49%-107.73M 2,118.43%123.5M 156.83%56.24M -413.46%-236.46M -7,685.33%-227.56M
Cash from discontinued investing activities
Investing cash flow 135.91%38.82M -123.50%-28.96M -98.54%819K 138.52%92.05M 109.17%20.93M -228.61%-108.09M 2,661.59%123.22M 156.38%55.99M -414.99%-238.99M -8,208.74%-228.18M
Financing cash flow
Cash flow from continuing financing activities -91.00%80K -98.05%27K -87.40%131K -99.18%3.54M -99.90%230K 889K 267.15%1.38M -99.48%1.04M 172.41%431.79M 21,899.25%232.16M
Net issuance payments of debt ---- ---- ---- --0 ---- ---- ---- ---- --0 ----
Net common stock issuance ---- ---- ---- --0 ---- ---- ---- ---- --432.45M --231.55M
Net preferred stock issuance ---- ---- ---- --0 ---- ---- ---- ---- --0 ----
Proceeds from stock option exercised by employees -50.10%491K -97.79%47K -59.14%1.45M 219.51%6.99M -82.12%347K --984K 756.45%2.12M --3.54M 538.19%2.19M 1,238.62%1.94M
Net other financing activities -332.63%-411K 97.30%-20K 47.38%-1.32M -21.22%-3.45M 91.20%-117K ---95K 31.23%-740K -465.38%-2.5M -4.17%-2.85M -14.97%-1.33M
Cash from discontinued financing activities
Financing cash flow -91.00%80K -98.05%27K -87.40%131K -99.18%3.54M -99.90%230K --889K 267.15%1.38M -99.48%1.04M 172.41%431.79M 21,899.25%232.16M
Net cash flow
Beginning cash position -69.53%75.72M 48.57%171.27M 170.25%170.92M 25.54%63.25M 25.38%135.98M 266.17%248.48M 4.02%115.28M 25.54%63.25M 285.58%50.38M 41.09%108.45M
Current changes in cash 97.62%-2.67M -171.70%-95.51M -99.11%461K 731.52%107.52M 175.92%34.71M -374.32%-112.37M 411.05%133.22M -14.13%51.96M -65.34%12.93M -72.54%-45.72M
Effect of exchange rate changes 276.12%236K -116.67%-39K -246.67%-110K 346.15%160K -53.25%237K 63.69%-134K 86.67%-18K 210.29%75K -600.00%-65K 5,533.33%507K
End cash Position -46.11%73.28M -69.53%75.72M 48.57%171.27M 170.25%170.92M 170.25%170.92M 25.38%135.98M 266.17%248.48M 4.02%115.28M 25.54%63.25M 25.54%63.25M
Free cash flow -651.92%-41.55M -900.25%-66.67M 89.55%-556K 105.85%10.68M 126.22%13.2M 87.31%-5.53M 117.51%8.33M 87.01%-5.32M -142.70%-182.4M -76.99%-50.32M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data